Advertisement
Table 2 KSHV+ EBV˗ PEL cell lines reported previously
| No. | Name of cell line | Reference | Patient | Site | HIV infection | KSHV | EBV | Lymphoid marker | B cell marker | T cell marker | Activation marker | Plasma cell marker | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CD45 | CD19 | CD20 | CD79a | CD3 | CD4 | CD30 | CD38 | CD138+ | ||||||||
| 1 | AP3 | [36] | 42 M | Ascites | yes | + | − | + | − | NT | − | − | NT | + | + | + |
| 2 | AP6 | [36] | 26 M | Pleural effusion | yes | + | − | NT | − | NT | − | − | NT | + | + | + |
| 3 | BC3 | [37] | 85 M | Pleural effusion | no | + | − | + | − | − | NT | − | − | + | + | NT |
| 4 | BCBL1 | [15] | 40 M | Ascites | yes | + | − | UN | UN | UN | UN | UN | UN | UN | UN | UN |
| 5 | BCP1- | [38] | 94 M | Pleural effusion | no | + | − | − | − | − | − | − | NT | − | + | NT |
| 6 | HH-B2 | [39] | UN | Pleural effusion | yes | + | − | + | − | − | NT | − | − | − | + | NT |
| 7 | TY1 | [14] | 47 M | Pericardial effusion | yes | + | − | + | − | − | UN | − | − | + | NT | NT |
| 8 | VG1- | [40] | 59 M | Pleural effusion | no | + | − | − | − | − | − | − | NT | + | + | NT |
| 9 | GTO | [16] | 39 M | Pericardial effusion | yes | + | − | + | − | − | − | − | + | − | + | + |
| 10 | SPEL | This study | 49 M | Pleural effusion | yes | + | − | + | − | − | − | − | − | + | + | + |
